This inventor holds 1 USPTO granted patent. Top assignee: Harvard College. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Daniel E. Jeffries
Introduction
Daniel E. Jeffries is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit nicotinamide N-methyltransferase (NNIMT). His work has implications for cancer treatment, showcasing the potential of innovative therapies in modern medicine.
Latest Patents
Daniel E. Jeffries holds a patent for "Inhibitors of nicotinamide N-methyltransferase, compositions and uses thereof." This patent discloses compounds and pharmaceutically acceptable salts that serve as inhibitors of NNIMT. The patent also details pharmaceutical compositions that include these compounds, along with methods for treating cancer and inhibiting tumor growth in subjects.
Career Highlights
Jeffries is affiliated with Harvard College, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical science through innovative solutions. With a focus on cancer treatment, he aims to contribute to the improvement of patient outcomes.
Collaborations
Some of his notable coworkers include Matthew D. Shair and Hanna Tukachinsky. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
Daniel E. Jeffries exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in cancer treatment, highlight the importance of research and development in creating effective therapies.